wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38701979-0BF78821-E9C7-40C6-B480-2E9AE2CEC143
Q38701979-0BF78821-E9C7-40C6-B480-2E9AE2CEC143
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38701979-0BF78821-E9C7-40C6-B480-2E9AE2CEC143
A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.
P2860
Q38701979-0BF78821-E9C7-40C6-B480-2E9AE2CEC143
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38701979-0BF78821-E9C7-40C6-B480-2E9AE2CEC143
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
514604f9d2283d7c300851c00fbeffefd5ba909d
P2860
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.